About 40 percent of the people currently advised to take statins would not be if they were assessed using new criteria, according to a study published on June 10 in JAMA Internal Medicine.
In 2023, the American Heart Association developed a risk assessment to evaluate a person’s risk of heart disease. The assessment, PREVENT, significantly reduces the number of people who must take statins to prevent heart disease.
